Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Acute Myeloid Leukaemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01826214
What this trial is testing

Study of Efficacy and Safety of LDE225 in Adult Patients With Relapsed/Refractory Acute Leukemia

Who this might be right for
Acute Leukemias
Novartis Pharmaceuticals 70
Early research (Phase 1)Ended earlyNCT00004058
What this trial is testing

12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
University of Medicine and Dentistry of New Jersey
Testing effectiveness (Phase 2)Study completedNCT01789255
What this trial is testing

Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+115 more
National Cancer Institute (NCI) 12
Early research (Phase 1)Study completedNCT01344876
What this trial is testing

Phase I Study of OPB-51602 in Patients With Hematologic Malignancies

Who this might be right for
Multiple MyelomaNon-Hodgkin LymphomaAcute Myeloid Leukemia+2 more
Otsuka Pharmaceutical Co., Ltd. 20
Early research (Phase 1)Ended earlyNCT03760523
What this trial is testing

Dose Escalation Study of Minnelide in Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
H. Lee Moffitt Cancer Center and Research Institute 27
Early research (Phase 1)Looking for participantsNCT06307054
What this trial is testing

CLL-1 CAR-NK Cells for Relapsed/Refractory AML

Who this might be right for
Relapsed Adult AMLRefractory AML
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 24
Testing effectiveness (Phase 2)Ended earlyNCT04956042
What this trial is testing

Study of Fosciclopirox in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Refractory Acute Myeloid LeukemiaRecurrent Acute Myeloid Leukemia
CicloMed LLC 18
Large-scale testing (Phase 3)Study completedNCT00422890
What this trial is testing

Treatment of Imminent Haematological Relapse in Patients With AML and MDS Following Allogeneic Stem Cell Transplantation With 5-azacitidine (Vidaza®)

Who this might be right for
Myeloid LeukemiaMyelodysplastic Syndrome
Technische Universität Dresden 10
Early research (Phase 1)Temporarily pausedNCT02333162
What this trial is testing

Intensity Modulated Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients With Relapsed Hematologic Cancers Undergoing a Second Donor Stem Cell Transplant

Who this might be right for
Previously Treated Myelodysplastic SyndromeRecurrent Adult Acute Lymphoblastic LeukemiaRecurrent Adult Acute Myeloid Leukemia+1 more
University of Chicago 30
Testing effectiveness (Phase 2)Study completedNCT00274846
What this trial is testing

Donor Peripheral Stem Cell Transplant in Treating Patients With Relapsed Acute Myeloid Leukemia

Who this might be right for
Leukemia
Masonic Cancer Center, University of Minnesota 21
Not applicableStudy completedNCT06429670
What this trial is testing

Real World Use of Azacitidine and Venetoclax in Acute Myeloid Leukemia in Frontline and Relapse/Refractory

Who this might be right for
Acute Myeloid Leukemia
Hospices Civils de Lyon 500
Testing effectiveness (Phase 2)Active Not RecruitingNCT05428969
What this trial is testing

Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological Malignancies

Who this might be right for
Acute Myeloid LeukemiaChronic Myelomonocytic LeukemiaMyelodysplastic Syndromes+1 more
Faron Pharmaceuticals Ltd 181
Not applicableStudy completedNCT02551718
What this trial is testing

High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia

Who this might be right for
Recurrent Acute Leukemia of Ambiguous LineageRecurrent Acute Lymphoblastic LeukemiaRecurrent Acute Myeloid Leukemia+3 more
University of Washington 34
Not applicableStudy completedNCT01419496
What this trial is testing

Study of Proteins in Promoting Chemotherapy Resistance in Samples From Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 40
Not applicableStudy completedNCT03860376
What this trial is testing

Ex Vivo Drug Sensitivity Testing and Mutation Profiling

Who this might be right for
Recurrent Childhood Acute Myeloid LeukemiaRecurrent Childhood Acute Lymphoblastic LeukemiaRecurrent Childhood Large Cell Lymphoma+11 more
Florida International University 25
Not applicableUnknownNCT05791890
What this trial is testing

GilteRInf 2022 Study (Gilteritinib Related Infections)

Who this might be right for
Acute Myeloid Leukemia
University of Rome Tor Vergata 78
Early research (Phase 1)Ended earlyNCT02319369
What this trial is testing

Safety, Tolerability and Pharmacokinetics of Milademetan Alone and With 5-Azacitidine (AZA) in Acute Myelogenous Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic Syndrome
Daiichi Sankyo 74
Early research (Phase 1)UnknownNCT05982756
What this trial is testing

Bortezomib Combined With DAG Regimen in the Treatment of Refractory/Relapsed AML

Who this might be right for
BortezomibAcute Myeloid Leukemia
Zhongnan Hospital 40
Early research (Phase 1)UnknownNCT05467254
What this trial is testing

Evaluate the Safety and Efficacy of CLL1+CD33 CAR-T in Patients With R/R AML

Who this might be right for
AML
Zhejiang University 20
Early research (Phase 1)Ended earlyNCT01455025
What this trial is testing

Study in Plerixafor and Granulocyte-colony Stimulating Factor Patients With Relapse Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
French Innovative Leukemia Organisation 11
Next Page